| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |